Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 3, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
February 14, 2025 SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
February 7, 2025 8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 4, 2025 4 Statement of changes in beneficial ownership of securities View HTML
February 4, 2025 4 Statement of changes in beneficial ownership of securities View HTML
February 4, 2025 4 Statement of changes in beneficial ownership of securities View HTML
February 4, 2025 4 Statement of changes in beneficial ownership of securities View HTML
February 4, 2025 4 Statement of changes in beneficial ownership of securities View HTML
February 3, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
February 3, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us